Table 1.

Patients characteristics for human bladder cancer tissue microarray

Clinical characteristic	TMA (All cases)	TMA (Subset w/p53 mutations)	TMA (Subset w/p53 mutations and chemotherapy)
Number of samples #	190	35	15
Age at cystectomy (years)
Median (range)	69 (38–87)	71 (43–87)	67 (43–81)
Gender:
Male	146	26	12
Female	44	9	3
T stage:
Ta	1	0	0
T1	8	1	0
T2	50	9	3
T3	108	22	10
T4	23	3	2
Lymph node status:
Negative	132	20	10
Positive (not available)	56 (2)	15	5
Sample tissue type:
Primary	186	34	14
Metastasis	4	1	1
Recurrence:
Yes/No (not available)	107/77 (6)	19/16	11/4
Vital status: (Dead/Alive)	105/85	17/18	9/6
Follow-up in months:
Median (range)	26.4 (0.2–168)	35.1 (1.7–87.2)	35.1 (4.9–83.9)
Expression of ARF:
Nucleolar	29	12	7
Non-Nucleolar or no expression (not available)	150 (11)	27	8
TP53 mutation or deletion (not available)	35 of 85 (105)	35/35	15/15
CDKN2A deletion	N/A	N/A	1/15
Cisplatin containing regimen:	N/A	15/35	15/35
gemcitabine/cisplatin			9
gemcitabine/carboplatin			3
gemcitabine/taxol/carboplatin			1
gemcitabine/taxol/cisplatin			1
etoposide/cisplatin			1